Press-release for stocks related to als

Prices are updated after-hours

tags : Als crawled date : 2021 - 12 - 15

save search

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results and Provides Business Update
Published: 2021-12-15 (Crawled : 23:00) - biospace.com/
CTXR | $0.8 -1.99% -2.02% 6.3M

Health Technology

| -54.83% | O: -1.81% H: 4.29% C: 4.29%
als financial results results

Navidea Biopharmaceuticals Completes Full Enrollment in Phase 2b Normative Database Study to Support its Rheumatoid Arthritis Program
Published: 2021-12-15 (Crawled : 22:00) - biospace.com/
NAVB | $0.042 50.69% 12K

Health Technology

| -96.77% | O: -1.61% H: 0.82% C: -4.92%
phase 2 als biopharma phase 2b rheumatoid arthritis enroll

Universe Pharmaceuticals INC Appoints Mr. Baochang Liu as Chief Operating Officer
Published: 2021-12-15 (Crawled : 22:00) - biospace.com/
UPC | $2.225 9.61% 8.76% 270K

Manufacturing

| 16.67% | O: 0.0% H: 1.15% C: 0.0%
als

Milestone Scientific CEO Arjan Haverhals to Participate in the Benzinga All Access Event on December 16th
Published: 2021-12-15 (Crawled : 21:00) - globenewswire.com
MLSS | $0.5714 0.23% 0.0% 100K

Health Technology

| -72.06% | O: 0.49% H: 2.93% C: 2.93%
als ceo milestone

Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum
Published: 2021-12-15 (Crawled : 21:00) - globenewswire.com
VRCA | $6.91 -2.13% -2.17% 200K

Health Technology

| -25.05% | O: 2.34% H: 7.05% C: -3.94%
vp-102 molluscum treatment fda als submission resubmission

Eagle Pharmaceuticals Receives FDA Approval for Vasopressin
Published: 2021-12-15 (Crawled : 21:00) - eagleus.com
EGRX | $4.505 2.62% 2.55% 140K

Health Technology

| -91.03% | O: 0.08% H: 0.59% C: -0.69%
fda als fda approval approval

QVC Teams up With Meals on Wheels and No Kid Hungry to Host Holiday Giving Event on the Retailer's Many Video Platforms
Published: 2021-12-15 (Crawled : 21:00) - prnewswire.com
QRTEB | $3.99 -2.68% -2.76% 1.3K

Retail Trade

| -48.75% | O: -2.25% H: 0.77% C: 0.64%
QRTEA | $1.02 3.97% 3.81% 1.7M

Retail Trade

| -87.26% | O: 1.3% H: 0.9% C: -2.57%
als qvc platform

Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals
Published: 2021-12-15 (Crawled : 19:00) - biospace.com/
LLY | $745.95 -0.64% -0.1% 1.7M

Health Technology

| 201.05% | O: 4.7% H: 0.0% C: 0.0%
alzheimer als approval alzheimer’s alzheimer's

Mirum Pharmaceuticals Added to NASDAQ Biotechnology Index
Published: 2021-12-15 (Crawled : 18:00) - biospace.com/
MIRM | $23.6 -1.05% -1.06% 400K

Health Technology

| 71.58% | O: 0.14% H: 5.46% C: 5.1%
als technology nasdaq index biotech iot

steroidi per tirarsi 15 minuti al giorno per far crescere la tua attività
Published: 2021-12-15 (Crawled : 17:00) - oncocyte.com
OCX J | $2.52 -2.7% -2.78% 37K

Health Technology

| 22.17% | O: 1.65% H: 0.0% C: 0.0%
als

Introducing AMP-UP RB from Autonomic Materials, Inc.
Published: 2021-12-15 (Crawled : 17:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M

Manufacturing

| -92.33% | O: 2.79% H: 0.0% C: 0.0%
als

Quoin Pharmaceuticals Signs Exclusive Distribution Agreement with Orpharm LLC for its Lead Asset, QRX003, for Netherton SyndromeOrpharm Gains Exclusive Rights to Commercialize QRX003 in Russia and CIS
Published: 2021-12-15 (Crawled : 15:30) - biospace.com/
QNRX | $0.725 -1.11% -1.12% 9.9K

Professional, Scientific, and T...

| -77.04% | O: 60.06% H: 1.18% C: -45.38%
qrx003 als russia distribution

Eiger BioPharmaceuticals Announces Second Positive Interim Analysis and Continuation of Dosing of Peginterferon Lambda in Phase 3 TOGETHER Study of Newly Diagnosed COVID-19 Patients
Published: 2021-12-15 (Crawled : 15:00) - biospace.com/
EIGR | $1.725 -1.45% 140K

Health Technology

| -67.88% | O: -0.56% H: 3.56% C: 3.18%
covid-19 als biopharma covid positive phase 3

Salarius Pharmaceuticals to Present at the Virtual Life Science Investor Forum
Published: 2021-12-15 (Crawled : 14:00) - globenewswire.com
SLRX A | $0.5105 -2.88% 8.8K

Commercial Services

| -7.02% | O: -3.45% H: 7.63% C: 0.32%
als life science

CSW Industrials Completes Acquisition of Shoemaker Manufacturing for $41.3 Million
Published: 2021-12-15 (Crawled : 14:00) - globenewswire.com
CSWI | $234.23 0.77% 0.77% 98K

Process Industries

| 102.05% | O: -2.02% H: 2.77% C: 2.33%
ema als acquisition trials trial

New "APP-ortunity" Report on Install Intent Reveals Surprise Shopping Apps Poised For Breakout Growth
Published: 2021-12-15 (Crawled : 13:30) - prnewswire.com
APPS | $1.905 2.42% 2.36% 1.9M

Technology Services

| -96.39% | O: 1.13% H: 7.57% C: 7.33%
als growth

Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor
Published: 2021-12-15 (Crawled : 13:30) - biospace.com/
JAZZ | $109.3 2.05% 2.01% 560K

Health Technology

| -12.4% | O: -0.93% H: 1.39% C: 0.5%
jzp385 treatment phase 2 als phase 2b trial enroll

NRx Pharmaceuticals Added to the Nasdaq® Biotech Index
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
NRXP | $3.025 -27.63% -38.18% 760K

Manufacturing

| -26.15% | O: -0.53% H: 1.78% C: -3.2%
NDAQ | $60.075 0.11% 0.11% 2.3M

Finance

| -70.55% | O: -1.62% H: 0.82% C: 0.79%
nasdaq als biotech index index biotech iot

Tonix Pharmaceuticals Added to the Nasdaq Biotechnology Index
Published: 2021-12-15 (Crawled : 12:30) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M

Health Technology